X0306 4 2019-10-16 true 0001706431 Vir Biotechnology, Inc. VIR 0001663801 Bill & Melinda Gates Foundation P.O. BOX 23350 SEATTLE WA 98102 true Common Stock 2019-10-16 4 C 0 2777777 A 2777777 D Series A-1 convertible preferred stock 2019-10-16 4 C 0 2222222 0 D Common Stock 2222222 0 D Series B convertible preferred stock 2019-10-16 4 C 0 555555 0 D Common Stock 555555 0 D Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. /s/ Connie Collingsworth, Chief Operating Officer and Chief Legal Officer 2019-10-16